09th week of 2017 patent applcation highlights part 11 |
Patent application number | Title | Published |
20170056432 | CANCER THERAPY USING BETA GLUCAN AND ANTIBODIES | 2017-03-02 |
20170056433 | GLUCANS | 2017-03-02 |
20170056434 | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES | 2017-03-02 |
20170056435 | Compositions Comprising Citrate and Applications Thereof | 2017-03-02 |
20170056436 | MOISTURE CURING ALKOXYSILANE POLYMERS | 2017-03-02 |
20170056437 | TOPICAL GELS AND METHODS OF USING THE SAME | 2017-03-02 |
20170056438 | NANOBUBBLE-CONTAINING COMPOSITION AND USE THEREOF | 2017-03-02 |
20170056439 | OXYGEN-ENRICHED WATER COMPOSITION, BIOCOMPATIBLE COMPOSITION COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | 2017-03-02 |
20170056440 | METHOD FOR MANUFACTURING HYDROGEN-SATURATED DEUTERIUM-DEPLETED WATER | 2017-03-02 |
20170056441 | NUTRITIONAL SUPPLEMENTS FOR THE PREVENTION AND RELIEF OF MUSCLE CRAMPS AND RELATED METHODS | 2017-03-02 |
20170056442 | ZEOLITE MOLECULAR SIEVES FOR THE REMOVAL OF TOXINS | 2017-03-02 |
20170056443 | CALCIUM SUPPLEMENT HAVING ENHANCED ABSORPTION | 2017-03-02 |
20170056444 | IRON-POLYSACCHARIDE COMPLEXES AND METHODS FOR THE PREPARATION THEREOF | 2017-03-02 |
20170056445 | SODIUM CONTAINING SOL-GEL DERIVED BIOACTIVE GLASSES AND USES THEREOF INCLUDING HEMOSTASIS | 2017-03-02 |
20170056446 | COMBINED AUTOLOGOUS BIOLOGIC AND COLD THERAPY TREATMENT OF SKIN INJURIES | 2017-03-02 |
20170056447 | Pharmaceutical Composition For Preventing Or Treating Sensorineural Hearing Loss Or Tinnitus Including Platelet-Rich Plasma And Method Using The Same | 2017-03-02 |
20170056448 | IMMUNE CELLS HAVING INCREASED IMMUNITY OR RESISTANCE TO AN IMMUNOSUPPRESSIVE CYTOKINE AND USE OF THE SAME | 2017-03-02 |
20170056449 | ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY | 2017-03-02 |
20170056450 | COMBINED AUTOLOGOUS BIOLOGIC AND COLD THERAPY TREATMENT OF SKIN INJURIES | 2017-03-02 |
20170056451 | LARGE INTESTINE CONTENTS' DIAGNOSIS AND ACOUSTIC CHARACTERIZATION | 2017-03-02 |
20170056452 | METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS | 2017-03-02 |
20170056453 | FERTILIZED EGG ISOLATE AND USES THEREOF | 2017-03-02 |
20170056454 | METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM | 2017-03-02 |
20170056455 | METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM | 2017-03-02 |
20170056456 | COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE | 2017-03-02 |
20170056457 | LACTOBACILLUS-BASED ECOLI INHIBITION | 2017-03-02 |
20170056458 | ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN OR ACTIVE FRAGMENT | 2017-03-02 |
20170056459 | Compositions and Methods for Aiding Phase 3 Recovery After Anesthesia | 2017-03-02 |
20170056460 | ANTI-CANCER DRUG COMPOSITION INCLUDING GANODERMA EXTRACT AND AMPHOTERICIN B | 2017-03-02 |
20170056461 | METHOD FOR PROTECTING NEURONAL CELLS COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF A CENTIPEDA MINIMA EXTRACT | 2017-03-02 |
20170056462 | USE OF A COMPOSITION COMPRISING ARABIC GUM (AG) FOR IMPROVING GUT IMPERMEABILITY | 2017-03-02 |
20170056463 | COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2017-03-02 |
20170056464 | COMPOSITION FOR MUSCULOSKELETAL PAIN | 2017-03-02 |
20170056465 | THERAPEUTIC COMPOSITIONS | 2017-03-02 |
20170056466 | Novel JNK inhibitor Molecules for Treatment of Various Diseases | 2017-03-02 |
20170056467 | OPTICALLY-BASED STIMULATION OF TARGET CELLS AND MODIFICATIONS THERETO | 2017-03-02 |
20170056468 | TREATMENT OF RESISTANT LESIONS | 2017-03-02 |
20170056469 | INDIVIDUALIZED TREATMENT OF EYE DISEASE | 2017-03-02 |
20170056470 | Peptides Of Syndecan-1 For Inhibiting Angiogenesis | 2017-03-02 |
20170056471 | BPI AND ITS CONGENERS AS RADIATION MITIGATORS AND RADIATION PROTECTORS | 2017-03-02 |
20170056472 | Peptide-Based In Vivo siRNA Delivery System | 2017-03-02 |
20170056473 | EBV ANTIGEN SPECIFIC T-CELL RECEPTOR AND USE THEREOF | 2017-03-02 |
20170056474 | FGF-18 COMPOUND DOSING REGIMEN | 2017-03-02 |
20170056475 | METHODS FOR TREATING METABOLIC DISORDERS USING FGF | 2017-03-02 |
20170056476 | SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES | 2017-03-02 |
20170056477 | Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier | 2017-03-02 |
20170056478 | RAPID-ACTING INSULIN COMPOSITIONS | 2017-03-02 |
20170056479 | EXTRACELLULAR MATRIX COMPOSITIONS | 2017-03-02 |
20170056480 | ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR THERAPEUTIC AND COSMETIC APPLICATIONS | 2017-03-02 |
20170056481 | Treating Infection | 2017-03-02 |
20170056482 | METHOD FOR TREATING SYSTEMIC DNA MUTATION DISEASE | 2017-03-02 |
20170056483 | High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease | 2017-03-02 |
20170056484 | PROPHYLACTIC NORMALIZATION OF CUTANEOUS WOUND REPAIR | 2017-03-02 |
20170056485 | CRYSTALLIZED XYLOSE ISOMERASE IN PREVENTION OF THE DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2017-03-02 |
20170056486 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS | 2017-03-02 |
20170056487 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS | 2017-03-02 |
20170056488 | NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS | 2017-03-02 |
20170056489 | Oligosialic Acid Derivatives, Methods of Manufacture, and Immunological Uses | 2017-03-02 |
20170056490 | IMMUNOGENIC COMPOSITION FOR USE IN THERAPY | 2017-03-02 |
20170056491 | ADENOVIRAL VECTOR-BASED VACCINE AGAINST ENTEROVIRUS INFECTION | 2017-03-02 |
20170056492 | PORCINE PARVOVIRUS | 2017-03-02 |
20170056493 | VIRUS LIKE VESICLES (VLVs) BASED VACCINES TO PREVENT OR TREAT CHRONIC HEPATITIS B VIRUS (HBV) INFECTION | 2017-03-02 |
20170056494 | MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME | 2017-03-02 |
20170056495 | TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD) | 2017-03-02 |
20170056496 | ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYCLOPHOSPHAMIDE | 2017-03-02 |
20170056497 | Method of Treating Protozoal Gastrointestinal Disorders in Immunocompromised Patients | 2017-03-02 |
20170056498 | FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS | 2017-03-02 |
20170056499 | SOLID ORAL FORM OF A MEDICINAL PREPARATION AND A METHOD FOR THE PRODUCTION THEREOF | 2017-03-02 |
20170056500 | FKBP52-Tau Interaction as a Novel Therapeutical Target for Treating the Neurological Disorders Involving Tau Dysfunction | 2017-03-02 |
20170056501 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | 2017-03-02 |
20170056502 | PERCUTANEOUS ABSORPTION COMPOSITION | 2017-03-02 |
20170056503 | PATCH PREPARATION CONTAINING AN ACID SCAVENGER | 2017-03-02 |
20170056504 | METHOD OF EXTENDING HALF-LIFE OF CRYSTALINE ANTIBODIES | 2017-03-02 |
20170056505 | POLYMER-BASED SUSTAINED RELEASE DEVICE | 2017-03-02 |
20170056506 | AMPHIPHILIC DRUG-DRUG CONJUGATES FOR CANCER THERAPY, COMPOSITIONS AND METHODS OF PREPARATION AND USES THEREOF | 2017-03-02 |
20170056507 | LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY | 2017-03-02 |
20170056508 | METHOD FOR SYNTHESIS OF A BIOPOLYMER DERIVATIVE, A BIOPOLYMER DERIVATIVE AND ITS USE | 2017-03-02 |
20170056509 | HYALURONIC ACID MODIFIED BY SPHINGOSINE-1-PHOSPHORIC ACID | 2017-03-02 |
20170056510 | TARGETED THERAPEUTICS | 2017-03-02 |
20170056511 | TARGETED THERAPEUTICS | 2017-03-02 |
20170056512 | BIPARTITE INHIBITORS OF BACTERIAL RNA POLYMERASE | 2017-03-02 |
20170056513 | THERAPEUTIC COMPOSITIONS COMPRISING N-ALKYL-HYDROXY POLYMERS | 2017-03-02 |
20170056514 | MULTI-ARM POLYMER PRODRUGS | 2017-03-02 |
20170056515 | COMPOSITIONS AND METHODS FOR TRANSPORT ACROSS THE BLOOD BRAIN BARRIER | 2017-03-02 |
20170056516 | Tetrameric Cytokines with Improved Biological Activity | 2017-03-02 |
20170056517 | Multi-arm linker constructs for treating pathological blood clots | 2017-03-02 |
20170056518 | Pharmaceuticals in joint-linker configurations for treating pathological blood clots | 2017-03-02 |
20170056519 | Fusion proteins for treating pathological blood clots | 2017-03-02 |
20170056520 | MULTI-ARM LINKER FOR TREATING REJECTION REACTION IN TRANSPLANTATION | 2017-03-02 |
20170056521 | FUSION PROTEIN FOR TREATING REJECTION REACTION IN TRANSPLANTATION | 2017-03-02 |
20170056522 | COMBINATION IL-2 IMMUNOCONJUGATE THERAPY | 2017-03-02 |
20170056523 | BI-SPECIFIC ANTIBODIES AND USES THEREOF | 2017-03-02 |
20170056524 | COMPOSITIONS AND METHODS FOR TARGETED EPIGENETIC MODIFICATION | 2017-03-02 |
20170056525 | APPLICATION OF RUTHENIUM COMPLEXES AS NUCLEIC ACID VECTORS OF TARGET CELL NUCLEUSES | 2017-03-02 |
20170056526 | COMPOSITIONS FOR GASTROINTESTINAL ADMINISTRATION OF RNA | 2017-03-02 |
20170056527 | THYMIDYLATE KINASE FUSIONS AND USES THEREOF | 2017-03-02 |
20170056528 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | 2017-03-02 |
20170056529 | NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED THERAPEUTIC PROTEIN | 2017-03-02 |
20170056530 | SYSTEMS AND METHODS FOR MATCHING ONCOLOGY SIGNATURES | 2017-03-02 |
20170056531 | Fluorscent Probes To Assess Stannous Containing Oral Care Products | 2017-03-02 |